Skip to Main Content

Paper Details

A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies.
Cancer Res Commun
0
2022
Author NameAffiliation
Rahul AggarwalUniversity of California San Francisco
Mark M MoasserUniversity of California San Francisco
  • 1 - 2

Datasets

Release 1.2